NGLFINE2,701.00

NGL Fine-Chem Limited

· Pharma & Health
₹ CrorePeersSYNCOMFJAGSNPHARMHESTERBIOAMRUTANJANWINDLASINDOCOSAIPARENTMcap ₹1,669 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment85.3142.1163.8163.8
+ Capital Work-in-Progress45.549.794.694.6
+ Goodwill0.00.00.20.2
+ Other Intangibles0.30.50.30.3
+ Long-term Loans0.00.00.50.5
+ Other Non-current Financial Assets8.81.09.49.4
Non-current Financial Assets8.81.09.99.9
+ Other Non-current Assets3.04.60.40.4
Total Non-current Assets142.9198.0269.1269.1
Current Assets
+ Inventories43.351.370.370.3
+ Current Investments53.659.739.239.2
+ Trade Receivables89.681.6130.9130.9
+ Cash & Cash Equivalents0.40.62.82.8
+ Other Bank Balances1.35.32.32.3
+ Other Current Financial Assets6.28.41.71.7
Current Financial Assets151.1155.5176.9176.9
+ Other Current Assets18.328.629.229.2
Total Current Assets212.7235.4276.4276.4
Total Assets355.5433.4545.5545.5
Equity
+ Equity Share Capital3.13.13.13.1
+ Other Equity / Reserves259.5279.3326.1326.1
Equity — Owners of Parent262.6282.4329.2329.2
Total Equity262.6282.4329.2329.2
Liabilities
+ Borrowings — Non-current0.725.356.456.4
+ Other Non-current Financial Liab3.43.4
Non-current Financial Liabilities0.725.359.859.8
+ Provisions — Non-current3.24.04.74.7
+ Deferred Tax Liabilities2.22.51.61.6
+ Other Non-current Liabilities0.20.20.20.2
Non-current Liabilities6.332.066.366.3
+ Borrowings — Current31.747.852.052.0
+ Trade Payables49.457.564.664.6
+ Other Current Financial Liab4.012.228.828.8
Current Financial Liabilities85.1117.5145.4145.4
+ Provisions — Current0.81.51.01.0
+ Current Tax Liabilities0.71.91.9
+ Other Current Liabilities1.71.7
Current Liabilities86.6119.0150.0150.0
Total Liabilities92.9151.0216.3216.3
Total Equity & Liabilities355.5433.4545.5545.5
Trade Payables — MSME split
+ Dues to Micro & Small — Current0.016.816.8
+ Dues to Other Creditors — Current57.547.847.8
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.